Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia
- 11 July 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 16 (11) , 1251-1262
Abstract
Introduction: Precision medicine provides individualized treatment of diseases through leveraging patient-to-patient variation. Aneurysmal subarachnoid hemorrhage carries tremendous morbidity and mortality with cerebral vasospasm and delayed cerebral ischemia proving devastating and unpredictable. Lack of treatment measures for these conditions could be improved through precision medicine. Areas covered: Discussed are the pathophysiology of CV and DCI, treatment guidelines, and evidence for precision medicine used for prediction and prevention of poor outcomes following aSAH. A PubMed search was performed using keywords cerebral vasospasm or delayed cerebral ischemia and either biomarkers, precision medicine, metabolomics, proteomics, or genomics. Over 200 peer-reviewed articles were evaluated. The studies presented cover biomarkers identified as predictive markers or therapeutic targets following aSAH. Expert commentary: The biomarkers reviewed here correlate with CV, DCI, and neurologic outcomes after aSAH. Though practical use in clinical management of aSAH is not well established, using these biomarkers as predictive tools or therapeutic targets demonstrates the potential of precision medicine.Keywords
Funding Information
- Mayo Clinic Center for Individualized Medicine
This publication has 130 references indexed in Scilit:
- Parenteral diclofenac infusion significantly decreases brain-tissue oxygen tension in patients with poor-grade aneurysmal subarachnoid hemorrhageCritical Care, 2013
- CSF and Serum Biomarkers Focusing on Cerebral Vasospasm and Ischemia after Subarachnoid HemorrhageStroke Research and Treatment, 2013
- Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trialThe Lancet, 2012
- Guidelines for the Management of Aneurysmal Subarachnoid HemorrhageStroke, 2012
- Hypoxia induces angiogenic factors in brain microvascular endothelial cellsMicrovascular Research, 2012
- Clinical assessment incorporating a personal genomeThe Lancet, 2010
- Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhageNeuroscience, 2010
- Endothelial Nitric Oxide Synthase Polymorphism (−786T→C) and Increased Risk of Angiographic Vasospasm After Aneurysmal Subarachnoid HemorrhageStroke, 2008
- Endothelial Nitric Oxide Synthase Gene Single-Nucleotide Polymorphism Predicts Cerebral Vasospasm after Aneurysmal Subarachnoid HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2008
- Axonal damage and outcome in subarachnoid haemorrhageJournal of Neurology, Neurosurgery & Psychiatry, 2006